Hwanin Pharmaceutical, 3Q Operating Profit 7.3 Billion KRW... 13% Decrease YoY
[Asia Economy Reporter Minwoo Lee] Hwanin Pharmaceutical announced on the 1st that it posted preliminary consolidated results for the third quarter of this year with sales of 45 billion KRW and operating profit of 7.3 billion KRW. Compared to the same period last year, sales increased by 3.8%, while operating profit decreased by 12.9%. Net profit for the period was recorded at 6 billion KRW, down 19.4% during the same period.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Uneducated Person" to Management Office Employee... Why Was the Resident Acquitted?
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
